Ariad Pharmaceuticals (ARIA -2.4%) slips today after pricing its 15.3M share offering at $19.60...
Ariad Pharmaceuticals (ARIA -2.4%) slips today after pricing its 15.3M share offering at $19.60 a share, a 1.3% discount to Wednesday's close. The company's float stands at around 166.3M shares. ARIA plans to use the proceeds for making and marketing its leukemia treatment Iclusig and for developing its other drug candidates.
From other sites
at Nasdaq.com (Mar 25, 2015)
at Nasdaq.com (Feb 26, 2015)
at Benzinga.com (Feb 20, 2015)
at Nasdaq.com (Jan 23, 2015)
at CNBC.com (Jan 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs